Autonomix Medical Revenue and Competitors

Houston, TX USA

Location

$11M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Autonomix Medical's estimated annual revenue is currently $5.4M per year.(i)
  • Autonomix Medical's estimated revenue per employee is $155,000
  • Autonomix Medical's total funding is $11M.

Employee Data

  • Autonomix Medical has 35 Employees.(i)
  • Autonomix Medical grew their employee count by 13% last year.

Autonomix Medical's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M1645%N/AN/A
#2
$13.8M89-7%N/AN/A
#3
$18.6M1203%$1.8MN/A
#4
$0.9M6-40%N/AN/A
#5
$4.2M270%N/AN/A
#6
$3.4M2247%N/AN/A
#7
$9.6M6229%N/AN/A
#8
$0.9M620%N/AN/A
#9
$1.7M1110%N/AN/A
#10
$15.2M98-8%N/AN/A
Add Company

What Is Autonomix Medical?

Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.\n\nWe are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

keywords:N/A

$11M

Total Funding

35

Number of Employees

$5.4M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.6M353%N/A
#2
$3.4M353%N/A
#3
$6.2M350%N/A
#4
$7.3M36-29%N/A
#5
$7.8M366%N/A